Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk

Breast Cancer Research and Treatment

Volumn 160, Issue 3, 2016, Pages 547-562

  Schonberg, Mara A ^a   Li, Vicky W ^a   Eliassen, A Heather ^b,c   Davis, Roger B ^a   LaCroix, Andrea Z ^d   McCarthy, Ellen P ^a   Rosner, Bernard A ^b,c   Chlebowski, Rowan T ^e   Hankinson, Susan E ^b,c,f   Marcantonio, Edward R ^a   Ngo, Long H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Breast cancer prediction; Competing risks; Older

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; FUNCTIONAL STATUS; HEALTH BEHAVIOR; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NATIONAL HEALTH SERVICE; PERSONALIZED MEDICINE; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; WOMEN'S HEALTH; BREAST TUMOR; CAUSE OF DEATH; FOLLOW UP; HEALTH SURVEY; MIDDLE AGED; MORTALITY; PROGNOSIS; REPRODUCIBILITY;

ADULT; BREAST NEOPLASMS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MORTALITY; POPULATION SURVEILLANCE; POSTMENOPAUSE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84992160354     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-4020-8     Document Type: Article

References (46)

1. Walter LC, Schonberg MA (2014) Screening mammography in older women: a review. JAMA 311(13):1336–1347
2. Nelson HD, Smith ME, Griffin JC, Fu R (2013) Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 158(8):604–614
3. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886
4. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111–1130
5. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K (2008) Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Int Med 148(5):337–347
6. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK (2012) Prognostic indices for older adults: a systematic review. JAMA 307(2):182–192
7. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
8. Berry SD, Ngo L, Samelson EJ, Kiel DP (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58(4):783–787
9. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695–706
10. Pepe MS, Mori M (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12(8):737–751
11. Liu Y, McCarthy EP, Ngo LH (2015) Predicting breast cancer mortality in the presence of competing risks using smartphone application development software. Int J Stat Med Res 4:322–330
12. de Glas NA, Kiderlen M, Vandenbroucke JP, de Craen AJ, Portielje JE, van de Velde CJ, Liefers GJ, Bastiaannet E, Le Cessie S (2016) Performing survival analyses in the presence of competing risks: a clinical example in older breast cancer patients. J Natl Cancer Inst 108(5):djv366
13. Colditz GA, Manson JE, Hankinson SE (1997) The Nurses’ Health Study: 20-year contribution to the understanding of health among women. J Womens Health 6(1):49–62
14. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5):894–900
15. Newcomb PA, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Willett WC, Stampfer MJ (2001) Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 153(11):1071–1078
16. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278(17):1407–1411
17. Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, Ochs-Balcom HM, Thomson CA, Caan BJ, Tinker LF et al (2015) Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol 1(5):611–621
18. Cook NR, Rosner BA, Hankinson SE, Colditz GA (2009) Mammographic screening and risk factors for breast cancer. Am J Epidemiol 170(11):1422–1432
19. Charlson ME, Ales KL, Simon R, MacKenzie CR (1987) Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med 147(12):2155–2161
20. Chaudhry S, Jin L, Meltzer D (2005) Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 43(6):607–615
21. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER (2009) Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med 24(10):1115–1122
22. Lee SJ, Lindquist K, Segal MR, Covinsky KE (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295(7):801–808
23. deLeeuw J (1992) Introduction to Akaike (1973) information theory and an extension of the maximum likelihood principle (PDF). In: Kotz S, Johnson NL (eds) Breakthroughs in statistics I. Springer, New York, pp 599–609
24. Justice AC, Covinsky KE, Berlin JA (1999) Assessing the generalizability of prognostic information. Ann Int Med 130(6):515–524
25. Daly L (1992) Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med 22(5):351–361
26. Statisical methods in diagnostic medicine using SAS software. http://www2.sas.com/proceedings/sugi30/211-30.pdf. Accessed June 15 2016
27. Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23(13):2109–2123
28. Harrell FE, Lee KL, Mark DB (1996) Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
29. Schonberg MA, Li VW, Eliassen AH, Davis RB, LaCroix AZ, McCarthy EP, Rosner BA, Chlebowski RT, Rohan TE, Hankinson SE et al. (2016) Performance of the breast cancer risk assessment tool among women age 75 years and older. J Natl Cancer Inst 108(3):djv348
30. Sweeney C, Blair CK, Anderson KE, Lazovich D, Folsom AR (2004) Risk factors for breast cancer in elderly women. Am J Epidemiol 160(9):868–875
31. Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, Millikan RC, Moorman PG, Neugut AI, Gammon MD (2007) Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat 102(3):365–374
32. Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, Stefanick ML, Tindle HA, Tong E, Rohan TE (2011) Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 342:d1016
33. U.S. Preventive Services Task Force (2009) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Int Med 151(10):716–726, W-236
34. Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC (2014) Cancer screening rates in individuals with different life expectancies. JAMA Int Med 174(10):1558–1565
35. WHI Protocols and Study Consents. https://www.whi.org/researchers/studydoc/SitePages/Protocol%20and%20Consents.aspx. Accessed June 18 2016
36. Beral V, Reeves G, Bull D, Green J (2011) Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 103(4):296–305
37. Fournier A, Mesrine S, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Chabbert-Buffet N (2014) Risk of breast cancer after stopping menopausal hormone therapy in the E3 N cohort. Breast Cancer Res Treat 145(2):535–543
38. Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell FA, Lane D et al (2012) Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomised placebo-controlled trial. Lancet Oncol 13(5):476–486
39. Schonfeld SJ, Pee D, Greenlee RT, Hartge P, Lacey JV Jr, Park Y, Schatzkin A, Visvanathan K, Pfeiffer RM (2010) Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol 28(14):2411–2417
40. Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER (2011) External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc 59(8):1444–1451
41. Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA (2007) Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst 99(22):1695–1705
42. Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40(11):807–814
43. Tice JA, Cummings SR, Ziv E, Kerlikowske K (2005) Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94(2):115–122
44. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, Benichou J, Gail MH (2006) Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 98(17):1215–1226
45. What is a standard drink? http://pubs.niaaa.nih.gov/publications/Practitioner/pocketguide/pocket_guide2.htm. Accessed June 15 2016
46. Breast Cancer Risk Assessment Tool Source Code. http://www.cancer.gov/bcrisktool/download-source-code.aspx. Accessed June 27 2016